The pharma pendulum swings back towards diversification
This article was originally published in Scrip
Executive Summary
“Diversification” is back in vogue as a Big Pharma strategy – just like it was in the 1960s and 1970s. Only this time the diversification strategy has different forms and flavours compared with that period.